期刊文献+
共找到220篇文章
< 1 2 11 >
每页显示 20 50 100
STUDIES ON COLOR TYPE VARIANTSFROM MUTAGENIZED PROTOPLASTS OFPORPHYRA HAITANENSIS CHANG ET ZHENG& P. YEZOENSIS UEDA (RHODOPHYCEASE ) 被引量:6
1
作者 严兴洪 《Chinese Journal of Oceanology and Limnology》 SCIE CAS CSCD 1993年第3期235-244,共10页
Isolated protoplasts from thalli of Porphyra haitanensis and Porphyra yezoensis were treated with colchicine or irradiated by ultraviolet (UV ). Several types of color variants were observed among the protoplast offsp... Isolated protoplasts from thalli of Porphyra haitanensis and Porphyra yezoensis were treated with colchicine or irradiated by ultraviolet (UV ). Several types of color variants were observed among the protoplast offspring. After treatment with colchicine: (1) 0.04-0.09% of red type variants in P. haitanensis were obtained; (2) The rate of red type variants and the variegated chimeral thalli composed of red type and wild type of sectors were 6.31- 1.11% in P. yezoensis. After irradiation with UV: (1) 3.5- 10.5% of red type variants in P. yezoensis were obtained: (2) 0.5-2-0% of red type variants and the variegated chimeral thalli composed of red type and wild type of sectors were obtained in P. haitanensis. Colchicine and UV’s mutangenic effects on P. yezoensis protoplasts were stronger than those on P. haitanensis protoplasts. The most efficient concentration of colchicine was 0.05%. The optimal length of UV-radiation was 1/2 min (radiation distance 5 cm). The red type variants induced, by colchicine 展开更多
关键词 Porphyra PROTOPLAST COLOR type variant variegated chimeral THALLUS
原文传递
Integrated Manufacturing Cell Formation Technology Orienting Multi-product Type and Variant Volume Production 被引量:2
2
作者 CHEN Huawei WANG Aimin +1 位作者 NING Ruxin SHAO Canxia 《Chinese Journal of Mechanical Engineering》 SCIE EI CAS CSCD 2011年第1期12-22,共11页
What is pursued by multi-product type and variant volume(MPTVV)production is rapid response and quick switching,so that structure of transferring line in manufacturing system is no longer unalterable.Cell formation(CF... What is pursued by multi-product type and variant volume(MPTVV)production is rapid response and quick switching,so that structure of transferring line in manufacturing system is no longer unalterable.Cell formation(CF)algorithm is the key technology of cellular manufacturing system(CMS).Currently,CF methods are mainly extended on the idea of group technology(GT)that covers a lot on analysis of resource capability matching and its algorithm.Various constraints are considered,but seldom utilized comprehensively.Aimed to the problem of manufacturing cell(MC)formation under MPTVV production mode,integrated formation technologies for typical MC as group type of cell(GC),flow type of cell(FC)and inherited cell(IC)are presented based on technical analysis of CF.Oriented to practical production constraints like delivery time,product batch,equipment ability,key machine,key part and machine sharing,etc,an integrated formation model is constructed and internal interrelations of these constraints are analyzed synthetically.Ulteriorly,formation goals of types of MCs and their formation procedures under joint effect of formation constraints and rules are spread.In case study,three highly balanced GC are formed first;then FC formation are implemented based on the same data which indicate good balancing effect of cell load and flow-style production for key tasks;When task is adjusted,a new scheme is constructed on the result of FC configuration by using IC formation method,and more optimal performance of flow-style production is manifested.The proposed comparative study of different type of cells strongly explains the validation of integrated MC formation in support of rapid manufacturing resource transformation under MPTVV production mode. 展开更多
关键词 multi-product type and variant volume production cell formation flow style manufacturing cell inheriting manufacturing cell
在线阅读 下载PDF
Association of gene variants with susceptibility to type 2 diabetes among Omanis 被引量:3
3
作者 Sawsan Al-Sinani Nicolas Woodhouse +12 位作者 Ali Al-Mamari Omaima Al-Shafie Mohammed Al-Shafaee Said Al-Yahyaee Mohammed Hassan Deepali Jaju Khamis Al-Hashmi Mohammed Al-Abri Khalid Al-Rassadi Syed Rizvi Yengo Loic Philippe Froguel Riad Bayoumi 《World Journal of Diabetes》 SCIE CAS 2015年第2期358-366,共9页
AIM:To investigate the association of 10 known common gene variants with susceptibility to type 2diabetes mellitus(T2D)among Omanis.METHODS:Using case-control design,a total of992 diabetic patients and 294 normoglycem... AIM:To investigate the association of 10 known common gene variants with susceptibility to type 2diabetes mellitus(T2D)among Omanis.METHODS:Using case-control design,a total of992 diabetic patients and 294 normoglycemic Omani Arabs were genotyped,by an allelic discrimination assay-by-design TaqMan method on fast real time polymerase chain reaction system,for the following gene variants:KCNJ11(rs5219),TCF7L2(rs7903146),CDKAL1(rs10946398),CDKN2A/B(rs10811661),FTO(rs9939609 and rs8050136),IGF2BP2(rs4402960),SLC30A8(rs13266634)CAPN10(rs3792267)and HHEX(rs1111875).T2D patients were recruited from the Diabetes Clinic(n=243)and inpatients(n=749)at Sultan Qaboos Univesity Hospital(SQUH),Muscat,Oman.Adult control participants(n=294)were volunteers from the community and from those visiting Family Medicine Clinic at SQU,for regular medical checkup.The difficulty in recruiting Omani participants with no family history of diabetes was the main reason behind the small number of control participants in this study.Almost all volunteers questioned had a relativewith diabetes mellitus.Inspite of the small number of normoglycemic controls in this study,this sample was sufficient for detection of genes and loci for common alleles influencing T2D with an odds ratio of≥1.3reaching at least 80%power.Data was collected from June 2010 to February 2012.RESULTS:Using binary logistic regression analysis,four gene variants showed significant association with T2D risk:KCNJ11(rs5219,P=5.8×10^(-6),OR=1.74),TCF7L2(rs7903146,P=0.001,OR=1.46),CDKAL1(rs10946398,P=0.002,OR=1.44)and CDKN2A/B(rs10811661,P=0.020,OR=1.40).The fixation index analysis of these four gene variants indicated significant genetic differentiation between diabetics and controls{[KCNJ11(rs5219),P<0.001],[TCF7L2(rs7903146),P<0.001],[CDKAL1(rs10946398),P<0.05],[CDKN2A/B(rs10811661),P<0.05]}.The highest genotype variation%between diabetics and controls was found at KCNJ11(2.07%)and TCF7L2(1.62%).This study was not able to detect an association of T2D risk with gene variants of IGF2BP2(rs4402960),SLC30A8(rs13266634),CAPN10(rs3792267)and HHEX(rs1111875).Moreover,no association was found between FTO gene variants(rs9939609 and rs8050136)and T2D risk.However,T2D risk was found to be significantly associated with obesity(P=0.002,OR=2.22);and with the Waist-to-Hip ratio(n=532,P=1.9×10^(-7),OR=2.4),[among males(n=234,P=1.2×10^(-4),OR=2.0)and females(n=298,P=0.001,OR=6.3)].CONCLUSION:Results confirmed the association of KCNJ11(rs5219),TCF7L2(rs7903146),CDKAL1(rs10946398)and CDKN2A/B(rs10811661)gene variants with susceptibility to T2D among Omani Arabs. 展开更多
关键词 type 2 DIABETES GENETICS Oman Casecontrol ASSOCIATION GENE variantS
暂未订购
VB数据类型Variant的性能分析
4
作者 李村合 《物探化探计算技术》 CAS CSCD 2001年第2期171-175,共5页
Variant是 VB2 .0及其以后版本的缺省数据类型 ,它是 VB中的一种特殊的数据类型 ,可以包含数值、字符串或日期数据 ,还可以包含特殊数值 Empty、Error及 Null等。Variant变量能够存储所有系统定义类型的数据。如果把它们赋予 Variant变... Variant是 VB2 .0及其以后版本的缺省数据类型 ,它是 VB中的一种特殊的数据类型 ,可以包含数值、字符串或日期数据 ,还可以包含特殊数值 Empty、Error及 Null等。Variant变量能够存储所有系统定义类型的数据。如果把它们赋予 Variant变量 ,则不必在这些数据的类型间进行转换 ,Visual Basic会自动根据上下文完成任何必要的转换。这样我们可以使用 Variant来替换任何数据类型 ,从而更有适应性。虽然使用方便灵活 ,但是 Variant比其它数据类型所占内存大 ,并且运行速度慢 ,应该有限制地使用。 展开更多
关键词 VISUALBASIC 数据类型 variant缺省类型 数值 字符串
在线阅读 下载PDF
Pharmacogenetic studies update in type 2 diabetes mellitus 被引量:6
5
作者 Shalini Singh Kauser Usman Monisha Banerjee 《World Journal of Diabetes》 SCIE CAS 2016年第15期302-315,共14页
Type 2 diabetes mellitus(T2DM) is a silent progressive polygenic metabolic disorder resulting from ineffective insulin cascading in the body. World-wide, about 415 million people are suffering from T2DM with a project... Type 2 diabetes mellitus(T2DM) is a silent progressive polygenic metabolic disorder resulting from ineffective insulin cascading in the body. World-wide, about 415 million people are suffering from T2DM with a projected rise to 642 million in 2040. T2DM is treated with several classes of oral antidiabetic drugs(OADs) viz. biguanides, sulfonylureas, thiazolidinediones, meglitinides, etc. Treatment strategies for T2DM are to minimize long-term micro and macro vascular complications by achieving an optimized glycemic control. Genetic variations in the human genome not only disclose the risk of T2DM development but also predict the personalized response to drug therapy. Inter-individual variability in response to OADs is due to polymorphisms in genes encoding drug receptors, transporters, and metabolizing enzymes for example, genetic variants in solute carrier transporters(SLC22A1, SLC22A2, SLC22A3, SLC47A1 and SLC47A2) are actively involved in glycemic/HbA1c management of metformin. In addition, CYP gene encoding Cytochrome P450 enzymes also play a crucial role with respect to metabolism of drugs. Pharmacogenetic studies provide insights on the relationship between individual genetic variants and variable therapeutic outcomes of various OADs. Clinical utility of pharmacogenetic study is to predict the therapeutic dose of various OADs on individual basis. Pharmacogenetics therefore, is a step towards personalized medicine which will greatly improve the efficacy of diabetes treatment. 展开更多
关键词 type 2 diabetes MELLITUS PHARMACOGENETICS Genetic variantS Oral ANTIDIABETIC drugs Personalized medicine
暂未订购
Presentation of signet ring cell type at carcinoma ventriculi of the patient aged 20 years old
6
作者 Afrim Avdaj Ugur Gozalan +3 位作者 Nexhmi Hyseni Hatim Baxhaku Sherif Krasniqi Shpejtim Rramanaj 《Case Reports in Clinical Medicine》 2013年第6期358-362,共5页
Introduction: Diffuse variant of GC is composed of gastric-type mucous cells, which generally do not form glands, but rather permit the mucosa and wall as scattered individual cells or small clusters in an “infiltrat... Introduction: Diffuse variant of GC is composed of gastric-type mucous cells, which generally do not form glands, but rather permit the mucosa and wall as scattered individual cells or small clusters in an “infiltrative” growth pattern. These cells appear to arise from the middle layer of the mucosa, and the presence of intestinal metaplasia is not a prerequisite. In this version, mucin formation expands the malignant cells and pushes the nucleus to the periphery, creating a “signet ring” conformation. If the signetring cells are more than 50% of the tumor, the tumor is classified as signetring cell carcinoma [1]. This case is important for reporting because we encountered for the first time such a carcinoma type, due to the new age and its atypical presentation. Case Presentation: We report a case of a 20 years Albanian old patient with Signet Ring Cell Type of Gastric CA. The patient was brought at the urgency with severe abdominal pain, nausea and peritoneal irritation. Clinical examination has been made in emergency, where we conclude the signs of peritoneal irritation, from native Ro no signs of pneumoperitoneum, while laboratory tests found a slight anemia (erythrocytes 3.36, HCT 25, HGB 8.6). Two hours later we repeated the native RTG and there were present the signs of pneumoperitoneum. It was indicated urgent surgical in-tervention. Intraoperatively, we found Ulcer duodenal perforation and?undertook the operation procedures by Roscoe Graham technique. Conclusions: At this age, it is rare, and it is difficult to detect in its early stages, because the signs and symptoms are often non-existent, non-specific, or mimic as an ulcer. The most common symptoms are early heartburn indigestion, abdominal pain or discomfort, vomiting, constipation, diarrhea or to feel of filling after a small meal, loss of appetite, weakness and fatigue. Less common symptoms are anemia and weight loss. 展开更多
关键词 Signet Ring Cell type GASTRIC Adenenocarcinoma DIFFUSE variant of GC
暂未订购
Differential expression of glial cell line-derived neurotrophic factor splice variants in the mouse brain 被引量:1
7
作者 Xiao-He Gu Heng Li +4 位作者 Lin Zhang Tao He Xiang Chai He Wei Dian-Shuai Gao 《Neural Regeneration Research》 SCIE CAS CSCD 2020年第2期270-276,共7页
Glial cell line-derived neurotrophic factor(GDNF) plays a critical role in neuronal survival and function. GDNF has two major splice variants in the brain,α-pro-GDNF and β-pro-GDNF, and both isoforms have strong neu... Glial cell line-derived neurotrophic factor(GDNF) plays a critical role in neuronal survival and function. GDNF has two major splice variants in the brain,α-pro-GDNF and β-pro-GDNF, and both isoforms have strong neuroprotective effects on dopamine neurons. However, the expression of the GDNF splice variants in dopaminergic neurons in the brain remains unclear. Therefore, in this study, we investigated the mRNA and protein expression of α-and β-pro-GDNF in the mouse brain by real-time quantitative polymerase chain reaction, using splice variant-specific primers, and western blot analysis. At the mRNA level,β-pro-GDNF expression was significantly greater than that of α-pro-GDNF in the mouse brain. In contrast, at the protein level,α-pro-GDNF expression was markedly greater than that of β-pro-GDNF. To clarify the mechanism underlying this inverse relationship in mRNA and protein expression levels of the GDNF splice variants, we analyzed the expression of sorting protein-related receptor with A-type repeats(SorLA) by real-time quantitative polymerase chain reaction. At the mRNA level, SorLA was positively associated with β-pro-GDNF expression, but not with α-pro-GDNF expression. This suggests that the differential expression of α-and β-pro-GDNF in the mouse brain is related to SorLA expression. As a sorting protein, SorLA could contribute to the inverse relationship among the mRNA and protein levels of the GDNF isoforms. This study was approved by the Animal Ethics Committee of Xuzhou Medical University, China on July 14, 2016. 展开更多
关键词 Δ78 locus BRAIN region DOPAMINERGIC neurons glial cell line-derived NEUROTROPHIC factor mouse BRAIN precursor protein α-pro-GDNF β-pro-GDNF sorting protein-related receptor with A-type REPEATS splice variants
暂未订购
Pharmacogenetics of type 2 diabetes mellitus: An example of success in clinical and translational medicine
8
作者 Antonio Brunetti Francesco S Brunetti Eusebio Chiefari 《World Journal of Translational Medicine》 2014年第3期141-149,共9页
The pharmacological interventions currently available to control type 2 diabetes mellitus(T2DM) show a wide interindividual variability in drug response, emphasizing the importance of a personalized, more effective me... The pharmacological interventions currently available to control type 2 diabetes mellitus(T2DM) show a wide interindividual variability in drug response, emphasizing the importance of a personalized, more effective medical treatment for each individual patient. In this context, a growing interest has emerged in recent years and has focused on pharmacogenetics, a discipline aimed at understanding the variability in patients' drug response, making it possible to predict which drug is best for each patient and at what doses. Recent pharmacological and clinical evidences indicate that genetic polymorphisms(or genetic variations) of certain genes can adversely affect drug response and therapeutic efficacy of oral hypoglycemic agents in patients with T2 DM, through pharmacokinetic- and/or pharmacodynamic-based mechanisms that may reduce the therapeutic effects or increase toxicity. For example, genetic variants in genes encoding enzymes of the cytochrome P-450 superfamily, or proteins of the ATP-sensitive potassium channel on the beta-cell of the pancreas, are responsible for the interindividual variability of drug response to sulfonylureas in patients with T2 DM. Instead, genetic variants in the genes that encode for the organic cation transporters of metformin have been related to changes in both pharmacodynamic and pharmacokinetic responses to metformin in metformin-treated patients. Thus, based on the individual's genotype, the possibility, in these subjects, of a personalized therapy constitutes the main goal of pharmacogenetics, directly leading to the development of the right medicine for the right patient. Undoubtedly, this represents an integral part of the translational medicine network. 展开更多
关键词 type 2 diabetes ANTI-DIABETIC DRUGS PERSONALIZED therapy Genetic variantS GENOME-WIDE association study
暂未订购
地方槐猪和外来瘦肉型猪种9个关联突变位点的遗传变异分析 被引量:1
9
作者 黄佳怡 张玉宏 许卫华 《畜牧与兽医》 CAS 北大核心 2025年第1期20-28,共9页
旨在研究中国本土槐猪和引入瘦肉型猪(杜洛克猪、大约克夏猪、长白猪)在生长育肥相关基因MC4R和MSTN、脊椎数量相关基因NR6A1和VRTN、肉质性状相关基因PHKG1和PRKAG3以及病原感染相关基因SYNGR2和FUT1这8个基因9个SNP位点的遗传变异特... 旨在研究中国本土槐猪和引入瘦肉型猪(杜洛克猪、大约克夏猪、长白猪)在生长育肥相关基因MC4R和MSTN、脊椎数量相关基因NR6A1和VRTN、肉质性状相关基因PHKG1和PRKAG3以及病原感染相关基因SYNGR2和FUT1这8个基因9个SNP位点的遗传变异特征。利用竞争性等位基因特异性PCR(KASP)和聚合酶链反应-限制性片段长度多态性(PCR-restriction fragment length polymorphism,PCR-RFLP)方法对突变位点进行基因分型,根据原始文献对各位点进行有利等位基因判定,并制作各猪种在各位点有利等位基因和不利等位基因的百分比示意图。结果:槐猪在NR6A1基因突变位点存在一定多态性,有利等位基因频率为0.24,其他位点表现为单一基因型,其中,PHKG1、PRKAG3突变位点为有利等位基因,而在MC4R、MSTN、VRTN、SYNGR2和FUT1突变位点为不利等位基因;杜洛克猪在MC4R、NR6A1、VRTN、SYNGR2和FUT1突变位点有利等位基因占优,然而,PHKG1基因不利等位基因仍有一定的比例;大约克夏猪在MC4R、SYNGR2、NR6A1和VRTN基因突变位点有利等位基因占优,而其他位点为不利等位基因;长白猪在MC4R、MSTN、PRKAG3(p.Val249Ile)和SYNGR2这4个基因突变位点不利基因占优;杜洛克猪在VRTN基因、长白猪在MC4R基因突变位点处于遗传不平衡状态(P<0.05)。以上结果为槐猪品种保护与利用以及瘦肉型猪种分子遗传标记选育提供了有益的信息。 展开更多
关键词 槐猪 瘦肉型猪 因果突变 分子遗传标记
在线阅读 下载PDF
A Variant of Fermat’s Diophantine Equation
10
作者 Serdar Beji 《Advances in Pure Mathematics》 2021年第12期929-936,共8页
A variant of Fermat’s last Diophantine equation is proposed by adjusting the number of terms in accord with the power of terms and a theorem describing the solubility conditions is stated. Numerically obtained primit... A variant of Fermat’s last Diophantine equation is proposed by adjusting the number of terms in accord with the power of terms and a theorem describing the solubility conditions is stated. Numerically obtained primitive solutions are presented for several cases with number of terms equal to or greater than powers. Further, geometric representations of solutions for the second and third power equations are devised by recasting the general equation in a form with rational solutions less than unity. Finally, it is suggested to consider negative and complex integers in seeking solutions to Diophantine forms in general. 展开更多
关键词 variant of Fermat’s Last Equation Positive Integer Solutions of New Fermat-type Equations Geometric Representations for Solutions of New Diophantine Equations
在线阅读 下载PDF
检测方式及变体类型对晚期ALK融合非小细胞肺癌预后影响的研究进展
11
作者 骆珊 王绎 +2 位作者 梁泓宇 杨一 谢华 《肿瘤预防与治疗》 2025年第10期918-926,共9页
间变性淋巴瘤激酶(anaplastic lymphoma kinase,ALK)融合基因是非小细胞肺癌(non-small cell lung cancer,NSCLC)重要的驱动基因突变之一,其检测方式多样且不断发展,而不同的ALK融合变体类型在NSCLC患者中的生物学行为和预后表现也存在... 间变性淋巴瘤激酶(anaplastic lymphoma kinase,ALK)融合基因是非小细胞肺癌(non-small cell lung cancer,NSCLC)重要的驱动基因突变之一,其检测方式多样且不断发展,而不同的ALK融合变体类型在NSCLC患者中的生物学行为和预后表现也存在差异。本文阐述了常见的ALK融合检测方法,包括基于荧光原位杂交、免疫组织化学、聚合酶链反应及新一代测序技术以及不同检测方式在NSCLC预后评估中的作用、特点及局限性,同时总结了临床研究及真实世界中不同ALK融合变体患者的治疗反应及预后结局,旨在为ALK融合NSCLC患者的精准诊断、个体化治疗及预后评估提供初步参考依据并提示相应的探索方向。 展开更多
关键词 ALK融合基因 非小细胞肺癌 检测方式 变体类型
暂未订购
咳嗽变异性哮喘、哮喘-慢性阻塞性肺病重叠与典型哮喘的肺通气功能及炎症指标的比较
12
作者 桂正章 叶璐 +2 位作者 周阳 王翎 金奕丰 《实用医学杂志》 北大核心 2025年第13期2065-2072,共8页
目的分析咳嗽变异性哮喘(cough-variant asthma,CVA)、哮喘-慢性阻塞性肺疾病重叠(asthma-COPD overlap,ACO)与典型哮喘(classic asthma,CA)患者的肺通气功能及炎症指标特征,明确二者在临床中识别及区分CVA、ACO与CA患者的应用价值。方... 目的分析咳嗽变异性哮喘(cough-variant asthma,CVA)、哮喘-慢性阻塞性肺疾病重叠(asthma-COPD overlap,ACO)与典型哮喘(classic asthma,CA)患者的肺通气功能及炎症指标特征,明确二者在临床中识别及区分CVA、ACO与CA患者的应用价值。方法收集2023年7月至2024年6月于苏州大学附属第一医院门诊就诊并诊断为支气管哮喘、CVA、ACO的共计483例患者的就诊资料,按照诊断分为CA、CVA、ACO三组。对比CA组与CVA组、CA组与ACO组患者的肺通气功能、呼出气一氧化氮分数(fractional exhaled nitric oxide,FeNO)、血嗜酸性粒细胞(eosinophil,EOS)、血清总IgE(total immunoglobulin E,tIgE)等检查结果,对有意义的检查结果行logistic回归分析,再行绘制受试者工作特征(receiver operating characteristic,ROC)曲线比较曲线下面积及对应截断值。结果CVA组与CA组的tIgE差异有统计学意义(P=0.018),而FeNO及EOS均差异无统计学意义。ACO组与CA组在tIgE、FeNO和EOS均差异无统计学意义(P>0.05)。最终使用FEV1%pred(OR=1.086,P=0.019)、FEV1/FVC(OR=1.153,P=0.023)、MEF50%pred(OR=0.922,P=0.045)构建CA与CVA的判别模型,绘制ROC曲线,FEV1%pred的AUC为0.680,P<0.001,约登指数为0.358,对应截断值为89.200;FEV1/FVC的AUC为0.684,P<0.001,约登指数为0.334,对应截断值为76.075;MEF50%pred的AUC为0.668,P<0.001,约登指数为0.309,对应截断值为59.800;三者联合检测的敏感度为0.909,特异度为0.514,阳性预测值为0.600,阴性预测值为0.873,AUC为0.773,P<0.001,约登指数为0.423。使用FEV1(OR=0.002,P=0.045)、FEV1%pred(OR=1.490,P=0.006)、FEV1/FVC(OR=0.749,P=0.005)构建CA与ACO患者的判别模型,绘制ROC曲线,FEV1的AUC为0.819,P<0.001,约登指数为0.532,对应截断值为2.060;FEV1%pred的AUC为0.788,P<0.001,约登指数为0.501,对应截断值为75.000;FEV1/FVC的AUC为0.891,P<0.001,约登指数为0.678,对应截断值为68.620;三者联合检测的敏感度为1.000,特异度为0.904,阳性预测值为0.771,阴性预测值为1.000,AUC为0.973,P<0.001,约登指数为0.904。结论CVA、ACO与CA在肺通气功能存在差异,上述判别模型分别纳入的肺通气功能测定结果对于临床症状难以区分的CA与CVA患者以及判断CA人群是否存在ACO具有良好的判别价值。 展开更多
关键词 典型哮喘 咳嗽变异性哮喘 哮喘-慢阻肺重叠 肺通气功能 2型炎症
暂未订购
中国人群弱部分D15型的精准检测及其对输血安全潜在影响的评估与应对策略
13
作者 章旭 周助人 +5 位作者 黄旭颖 李丽春 李伟伟 侯萍 李晓丰 李剑平 《中国输血杂志》 2025年第8期1030-1034,1049,共6页
目的探讨精准检测弱部分D15型方法及其对输血安全的影响和应对策略。方法采用微板法、间接抗球蛋白试管法和抗人球蛋白微柱凝胶卡法等多种血清学方法相结合检测RhD阴性和RhD变异型标本。RhD阴性标本采用全血直接PCR扩增方法筛选RHD基因,... 目的探讨精准检测弱部分D15型方法及其对输血安全的影响和应对策略。方法采用微板法、间接抗球蛋白试管法和抗人球蛋白微柱凝胶卡法等多种血清学方法相结合检测RhD阴性和RhD变异型标本。RhD阴性标本采用全血直接PCR扩增方法筛选RHD基因,RhD变异型标本和RhD阴性筛选含有RHD基因标本进行RHD基因全编码区基因测序,确认其基因型,并结合血清学检测结果进行回顾性分析。结果615549例初次献血健康捐献者中检测到RhD阴性表型标本3401例和RhD变异型标本156例,3401例RhD阴性中检测到1054例标本含有RHD基因,156例RhD变异型标本和1054例标本血清学阴性标本采用基因测序技术共检测到89例标本含有RHD^(*)15(c.845G>A)等位基因。结论血清学检测技术和基因分型技术相结合精准检测RhD血型,确保输血安全。 展开更多
关键词 弱部分D15型 RhD变异型 精准检测 输血安全
原文传递
诸版本《大智度论》异文类型试析
14
作者 张福国 《枣庄学院学报》 2025年第4期70-76,共7页
《大智度论》编写时代明确,口语性强,版本较多,异文不少,内容扎实,类型丰富,是研究中古汉语的理想语料。文章主要以《大智度论》为研究对象,比勘其异文条目,从字、词、句三个角度分析归纳其异文类型,发掘其异文材料的文字学价值。
关键词 《大智度论》 异文 类型
在线阅读 下载PDF
3例NPR2基因变异相关矮小症临床分析及3种变异体外功能验证
15
作者 张淑颖 连群 +2 位作者 蔡丽华 王辰璐 许珊珊 《罕少疾病杂志》 2025年第9期1-4,共4页
目的 厦门大学附属第一医院发现3例NPR2基因变异伴骨骼畸形的矮小患儿,拟通过国内外文献报道、生信分析及体外功能验证,对NPR2基因变异所致矮小患者的临床表现、治疗及可能致病的机制进行分析。方法 通过医院HIS系统对患者的临床资料进... 目的 厦门大学附属第一医院发现3例NPR2基因变异伴骨骼畸形的矮小患儿,拟通过国内外文献报道、生信分析及体外功能验证,对NPR2基因变异所致矮小患者的临床表现、治疗及可能致病的机制进行分析。方法 通过医院HIS系统对患者的临床资料进行收集汇总。对NPR2基因变异体进行软件功能预测。用慢病毒转染293T细胞构建野生型及3种变异型稳定转染细胞。用酶联免疫分析方法测定cGMP水平。用蛋白印迹方法测定NPRB蛋白表达量。结果 报道了2位携带NPR2基因p.R787W杂合变异的特发性矮小患者及1位NPR2基因p.E906G及p.R976H复合杂合变异的Maroteaux型肢端肢中发育不全(AMDM)患者,该2种变异均为新变异,尚未被文献报道。3名患者由不同程度的骨骼畸形。体外功能验证结果:与野生型细胞相比,3种变异型细胞c GMP水平均下降,差异具有统计学意义,其NPRB蛋白表达量无统计学差异。结论 对严重身材矮小且伴有骨骼畸形的患者,应进行基因检测寻找其遗传病因。NPR2基因变异导致矮小的机制尚不明确,仍需进一步探索。 展开更多
关键词 NPR2基因 NPRB蛋白 基因变异 身材矮小 Maroteaux型肢端肢中发育不全 特发性矮小
暂未订购
穴位埋针联合止咳1号方治疗咳嗽变异性哮喘(风痰犯肺型)疗效观察
16
作者 黄绮芸 葛文逸 +2 位作者 陈照娣 邵妤 张瑾 《黑龙江医药》 2025年第5期1003-1006,共4页
目的:探究穴位埋针联合止咳1号方治疗咳嗽变异性哮喘(CVA)风痰犯肺型患者的效果。方法:选取2021年8月—2023年10月上海市普陀区中医医院收治的120例CVA风痰犯肺型患者,随机分为两组,每组60例。对照组行布地奈德福莫特罗治疗,观察组加以... 目的:探究穴位埋针联合止咳1号方治疗咳嗽变异性哮喘(CVA)风痰犯肺型患者的效果。方法:选取2021年8月—2023年10月上海市普陀区中医医院收治的120例CVA风痰犯肺型患者,随机分为两组,每组60例。对照组行布地奈德福莫特罗治疗,观察组加以穴位埋针、止咳1号方治疗。对比两组治疗效果。结果:与对照组比,观察组治疗总有效率更高,治疗后随访12周的复发率更低;观察组治疗后的各中医证候评分及日间、夜间咳嗽症状评分、呼出气一氧化氮(FeNO)更低,各肺功能指标更高,有统计学差异(P<0.05);两组不良反应发生率对比无统计学差异(P>0.05)。结论:穴位埋针联合止咳1号方可缓解CVA风痰犯肺型咳嗽等症状,有效控制气道炎症,加速肺功能恢复,且复发风险低,无严重不良反应。 展开更多
关键词 咳嗽变异性哮喘 风痰犯肺型 穴位埋针 止咳1号方
暂未订购
栓皮栎不同变异类型的优良性分析 被引量:20
17
作者 任耀忠 张文辉 周建云 《中南林业科技大学学报》 CAS CSCD 北大核心 2013年第6期60-63,共4页
为加快栓皮栎遗传改良,培育优良新品种,提高栓皮栎树种造林质量和增加林业经济效益,运用模糊数学隶属函数综合评判法,对4个栓皮栎不同变异类型的栓皮特性、速生性、抗旱性进行分析和综合评价。结果表明:4个栓皮栎变异类型的栓皮优良性... 为加快栓皮栎遗传改良,培育优良新品种,提高栓皮栎树种造林质量和增加林业经济效益,运用模糊数学隶属函数综合评判法,对4个栓皮栎不同变异类型的栓皮特性、速生性、抗旱性进行分析和综合评价。结果表明:4个栓皮栎变异类型的栓皮优良性为厚皮深裂型>厚皮浅裂型>薄皮深裂型>薄皮浅裂型;速生性为厚皮深裂>薄皮浅裂>厚皮浅裂>薄皮深裂;抗旱性为薄皮深裂型>薄皮浅裂型>厚皮浅裂型>厚皮深裂型;综合优良性为厚皮深裂型>厚皮浅裂型>薄皮深裂型>薄皮浅裂型。厚皮深裂型是栓皮栎天然变异类型中的最佳变异类型,因当作为首选类型,进行保护和定向培育。 展开更多
关键词 栓皮栎 变异类型 优良性分析 综合评价
在线阅读 下载PDF
麻黄厚朴汤辅助治疗小儿咳嗽变异性哮喘寒饮伏肺证59例临床观察
18
作者 罗延昭 何春风 《中医儿科杂志》 2025年第2期56-60,共5页
目的观察麻黄厚朴汤辅助治疗小儿咳嗽变异性哮喘(CVA)寒饮伏肺证的临床疗效及对肺功能和炎症因子的影响。方法选取2021年1月至2022年12月丽水市人民医院儿科收治的118例CVA寒饮伏肺证患儿,按照随机数字表法分为对照组和治疗组,各59例。... 目的观察麻黄厚朴汤辅助治疗小儿咳嗽变异性哮喘(CVA)寒饮伏肺证的临床疗效及对肺功能和炎症因子的影响。方法选取2021年1月至2022年12月丽水市人民医院儿科收治的118例CVA寒饮伏肺证患儿,按照随机数字表法分为对照组和治疗组,各59例。对照组给予常规西药治疗,治疗组在对照组治疗方法的基础上联合麻黄厚朴汤加味。2组均连续治疗1周后统计临床疗效。结果对照组总有效率为83.05%(49/59),治疗组为96.61%(57/59),2组比较,差异有统计学意义(P<0.05)。治疗前2组中医证候评分比较,差异无统计学意义(P>0.05),具有可比性;治疗后2组中医证候评分均显著下降,与同组治疗前比较,差异有统计学意义(P<0.05),且治疗组各项评分下降更显著(P<0.05)。治疗前2组用力肺活量(FVC)、第1秒用力呼气量(FEV_(1))、FEV_(1)/FVC水平比较,差异无统计学意义(P>0.05),具有可比性;治疗后2组FVC、FEV_(1)、FEV_(1)/FVC水平均显著升高,与同组治疗前比较,差异有统计学意义(P<0.05),且治疗组上述指标升高更显著(P<0.05)。治疗前2组血清炎症因子超敏C反应蛋白(hs-CRP)、白细胞介素-17(IL-17)、白细胞介素-23(IL-23)水平比较,差异无统计学意义(P>0.05),具有可比性;治疗后2组上述指标水平均显著下降,与同组治疗前比较,差异有统计学意义(P<0.05),且治疗组上述指标下降更显著(P<0.05)。对照组不良反应发生率为15.25%(9/59),治疗组为3.38%(2/59),2组比较,差异有统计学意义(P<0.05)。结论麻黄厚朴汤辅助治疗小儿CVA寒饮伏肺证,能明显改善患儿的临床症状和肺功能,降低血清炎症因子水平,安全性高,值得临床推广应用。 展开更多
关键词 咳嗽变异性哮喘 小儿 寒饮伏肺证 麻黄厚朴汤 临床观察
原文传递
变叶海棠变异类型的研究 被引量:21
19
作者 成明昊 李晓林 +3 位作者 王玫 曾维光 吴福寿 金强 《园艺学报》 CAS CSCD 北大核心 1992年第3期233-239,共7页
采用现代植物分类学的居群概念和形象化散点图法,研究了变叶海棠的两个居群内的变异与分化,证明四川阿坝州变叶海棠的变异类型是变叶海棠×陇东海棠的自然杂交种,并显出了杂种偏母型的图象。由居群内的变异分化出的地方宗,是变叶海... 采用现代植物分类学的居群概念和形象化散点图法,研究了变叶海棠的两个居群内的变异与分化,证明四川阿坝州变叶海棠的变异类型是变叶海棠×陇东海棠的自然杂交种,并显出了杂种偏母型的图象。由居群内的变异分化出的地方宗,是变叶海棠×陇东海棠的自然杂交变种。 变叶海棠×陇东海棠的人工杂交和对子代(F_1)的细胞遗传学分析及形态鉴定,证明了上述结论。 展开更多
关键词 变异类型 居群 地方种 偏母型 海棠
在线阅读 下载PDF
杜仲优良种源区与类型选择的研究 被引量:4
20
作者 张博勇 张康健 +1 位作者 王亚琴 白明生 《西北林学院学报》 CSCD 北大核心 2003年第4期32-34,共3页
对全国7个杜仲主产区杜仲叶的有效成分含量进行了测定和比较分析,认为陕西南部、四川东北部、湖南西北部和贵州西北部为我国杜仲的优良种源区。对同一立地条件下的杜仲皮、叶变异类型进行了有效成分含量测定,认为杜仲光皮和小叶类型为... 对全国7个杜仲主产区杜仲叶的有效成分含量进行了测定和比较分析,认为陕西南部、四川东北部、湖南西北部和贵州西北部为我国杜仲的优良种源区。对同一立地条件下的杜仲皮、叶变异类型进行了有效成分含量测定,认为杜仲光皮和小叶类型为有效成分含量高的变异类型。 展开更多
关键词 杜仲 种源区 类型 有效成分
在线阅读 下载PDF
上一页 1 2 11 下一页 到第
使用帮助 返回顶部